Amplyx Pharmaceuticals
UEI: N4A8X52DCND5
• CAGE: 4TDM0
Overview
Parent Awardee
Company Description
How patients facing serious illnesses can learn more about requesting pre-approval access to investigational drugs.
Keywords
Pharmaceutical, development
Name
Amplyx Pharmaceuticals
Website
Headquarters
San Diego, CA
United States
United States
Most Recent Award
April 19, 2019
Calculating
Federal contract and grant recipient
AMPLYX PHARMACEUTICALS, INC.
dba AMPLYX PHARMACEUTICALS
(UEI N4A8X52DCND5, CAGE 4TDM0)
is headquartered in San Diego CA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in March 2006 and
federally registered in
July 2007.
Federal Award Analysis
Amplyx Pharmaceuticals federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
AMPLYX PHARMACEUTICALS, INC.
DBA
AMPLYX PHARMACEUTICALS
Division Name
AMPLYX PHARMACEUTICALS
Division Number
AMPLYX PHA
UEI
N4A8X52DCND5
CAGE Code
4TDM0
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
March 23, 2006
Initial Registration
July 11, 2007
Last Registration
Oct. 12, 2022
Registration Activation
July 15, 2021
Registration Expiration
Oct. 12, 2022
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported PSC
Accepts Credit Cards
No
People
Vendor contacts at Amplyx Pharmaceuticals
Contract Awards
Amplyx Pharmaceuticals prime contract awards
Grant Awards
Amplyx Pharmaceuticals direct grants
Subgrant Awards
Amplyx Pharmaceuticals subgrant awards
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
Amplyx Pharmaceuticals